FSCB
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| fibrous sheath CABYR binding protein | MIM:611779 | Ensembl:ENSG00000189139 | HGNC:HGNC:20494 | PA162389023 | 14q21.2 |
GO terms in FSCB
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | ISS | GO:0033234 | negative regulation of protein sumoylation |
| CC | IEA | GO:0031514 | motile cilium |
Gene expression in normal tissue: FSCB
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in FSCB
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD84 | Lovastatin acid | 3 |
| iGMDRD584 | VER 155008 | 2 |
| iGMDRD512 | nutlin 3 | 3 |
| iGMDRD150 | RITA | 2 |
| iGMDRD560 | MK-2206 | 3 |
| iGMDRD116 | CD437 | 5 |
| iGMDRD499 | PDMP | 3 |
| iGMDRD435 | BI-2536 | 3 |
| iGMDRD883 | CIL55A | 1 |
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD267 | Oligomycin A | 3 |
| iGMDRD414 | MST-312 | 2 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD366 | PI-103 | 2 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD505 | Pevonedistat | 8 |
| iGMDRD420 | Leucascandrolide A | 4 |
| iGMDRD427 | ABT737 | 3 |
| iGMDRD781 | Sirolimus | 2 |
| iGMDRD483 | SCH-529074 | 2 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD61 | Kinetin riboside | 2 |
| iGMDRD152 | 179324-69-7 | 2 |
| iGMDRD316 | N9-Isopropyl-olomoucine | 2 |
| iGMDRD280 | CYTOCHALASIN B | 5 |
| iGMDRD297 | Austocystin D | 5 |
| iGMDRD255 | SB225002 | 6 |
| iGMDRD802 | 4-methylfasudil | 2 |
| iGMDRD207 | Capsaicin | 2 |
| iGMDRD399 | Selumetinib | 1 |
| iGMDRD887 | Compound 23 citrate | 5 |
| iGMDRD562 | Navitoclax | 2 |
| iGMDRD369 | TGX-115 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in FSCB
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.